Intraportal acetylcholine reverses insulin resistance caused by chronic bile duct ligation.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Proceedings of the Western Pharmacology Society

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(98)80707-1PMID 9836233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption.

  1996cited by this paper
• Insulin sensitivity tested with a modified euglycemic technique in cats and rats.

  1996cited by this paper
• Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration.

  1996cited by this paper
• Induction of insulin resistance by cholinergic blockade with atropine in the cat.

  1995cited by this paper
• Insulin resistance produced by hepatic denervation or muscarinic cholinergic blockade.

  1994cited by this paper
• Insulin resistance of glucose response produced by hepatic denervations.

  1993cited by this paper
• Hepatic blood volume responses and compliance in cats with long‐term bile duct ligation

  1993cited by this paper
• Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis

  1991cited by this paper
• Glucose and insulin metabolism in cirrhosis.

  1989cited by this paper
• The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis

  1988cited by this paper

• Hepatalin: The missing link in prediabetes, obesity, and type 2 diabetes.

  2023cites this paper
• Obesity as an Early Symptom of the AMIS Syndrome

  2014cites this paper
• Fast-to-fed shift in glucose homeostasis: clues to an earlier detection of human prediabetic states

  2010cites this paper
• Synergistic protection by S-adenosylmethionine with vitamins C and E on liver injury induced by thioacetamide in rats.

  2006cites this paper
• Increased incidence of hepatic insulin-sensitizing substance (HISS)-dependent insulin resistance in female rats prenatally exposed to ethanol.

  2005cites this paper
• A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis.

  2004cites this paper
• Pharmaceutical reversal of insulin resistance.

  2004cites this paper
• Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver.

  2004cites this paper
• Atherosclerosis, Hypertension and Diabetes

  2003cites this paper
• A Proposed New Paradigm for Insulin Resistance

  2003cites this paper
• Practice and principles of pharmacodynamic determination of HISS‐dependent and HISS‐independent insulin action: Methods to quantitate mechanisms of insulin resistance

  2003cites this paper
• New Paradigm for Insulin Resistance: the Hiss Story

  2003cites this paper
• New paradigm for the mechanism and treatment of insulin resistance.

  2002cites this paper
• Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting.

  2001cites this paper
• The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes.

  1999cites this paper
• Rapid insulin sensitivity test (RIST).

  1998cites this paper